サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1684379

哺乳類細胞発酵技術の世界市場：種類別・用途別・最終用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

Mammalian Cell Fermentation Technology Market, By Type, By Application, By End-use, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 311 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
哺乳類細胞発酵技術の世界市場：種類別・用途別・最終用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2025年02月04日
発行: AnalystView Market Insights
ページ情報: 英文 311 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

哺乳類細胞発酵技術の市場規模は2024年に507億8,943万米ドルとなり、2025年から2032年にかけてCAGR 8.99％で拡大

哺乳類細胞発酵技術の市場力学

生物製剤とバイオシミラーの需要増加が市場成長を促進

哺乳類細胞発酵技術産業は、バイオシミラーや生物製剤に対する需要の高まりにより、著しい上昇を目の当たりにしています。これらの治療は、感染症、がん、自己免疫疾患など様々な症状を管理する上で重要です。さらに、製薬会社が新規生物製剤の創製により多くの投資を行っているため、哺乳類細胞発酵技術は拡大し続けています。しかし、この技術の普及を抑制する重要な要因は、その製造工程に関連する費用の高さです。さらに、がん、糖尿病、心臓病などの慢性疾患の増加は、哺乳類細胞発酵技術市場の成長をもたらしました。多くの疾病が長期的な治療を必要とし、多くの場合生物製剤を使用するため、哺乳類細胞発酵技術に対する需要が続いています。その結果、哺乳類細胞発酵技術市場は、慢性疾患の増加とともにバイオシミラーや生物製剤に対する一定の需要により、今後数年間で成長すると予測されます。

哺乳類細胞発酵技術市場：主な考察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2025-2032年）に約8.99%のCAGRで毎年成長すると推定されます。

種類別では、チャイニーズハムスター卵巣（CHO）細胞発酵は2024年に最大市場シェアを示すと予測されました。

用途別では、モノクローナル抗体が2024年の主要用途です。

最終用途別では、2024年にはCMOとCDMOが主要な最終用途でした。

地域別では、北米が2024年の主要収益源です。

哺乳類細胞発酵技術市場：セグメンテーション分析

世界の哺乳類細胞発酵技術市場は、種類、用途、最終用途、地域に基づいてセグメント化されます。

市場は種類別に次のように区分されます：ベビーハムスター腎臓（BHK）細胞発酵、チャイニーズハムスター卵巣（CHO）細胞発酵、ヒト胚性腎臓（HEK）細胞発酵、マウス骨髄腫細胞発酵、その他です。チャイニーズハムスター卵巣（CHO）細胞発酵分野が市場を独占すると予想されます。CHO細胞は、複雑な治療用タンパク質を効率的に製造できることから、絶大な注目を集めています。さらに、培養培地や培養条件の最適化、細胞株開発強化のための遺伝子工学技術の進歩、強固な規制環境など、さまざまな要因が需要の増加に寄与しています。

市場は用途別に、酵素、ホルモン、モノクローナル抗体、組み換えタンパク質、ワクチン、その他の6つのカテゴリーに分類されます。モノクローナル抗体分野は、診断および治療用途で抗体が果たす重要な役割に起因する高い採用率から、堅牢な生産方法に対する需要が高まっており、市場シェアは最も高いとみられます。さらに、細胞株開発、バイオリアクター技術、バイオプロセス技術の進歩が、製品の品質向上、高収率、効率的な生産工程につながり、同分野の爆発的な拡大に拍車をかけています。同様に、正確な標的治療の必要性や慢性疾患の増加も、哺乳類抗体の需要を促進しています。

市場は最終用途に基づき、学術・研究機関、バイオ製薬企業、CMO・CDMOの3つに分類されます。CMO・CDMO分野は、CDMO・CMOが得意とする複雑な製造技術により、予測期間中も優位性を維持すると思われます。これらの組織は、製造工程のアウトソーシングを目指す企業に簡素で手頃なソリューションを提供し、企業は開発と研究に専念できます。さらに、品質基準や規制要件はより厳しくなっているため、製薬企業は、これらの要求を満たす熟練度を維持する信頼できるCMOやCDMOと協力する必要があります。

哺乳類細胞発酵技術市場：地域別分析

北米が哺乳類細胞発酵技術市場で最大のシェアを占めています。市場開拓の背景には、同地域の高度に発達した医療部門、有利な政府規制、重要なバイオ医薬品企業の強力なプレゼンスがあります。さらに、生物製剤やバイオシミラーに対する需要の高まり、慢性疾患の罹患率の上昇が、この地域の市場成長を牽引しています。

アジア太平洋地域は、訓練を受けたスタッフが低コストで入手しやすいこと、規制環境が良好であること、多国籍企業による投資が増加していることなどから、急速に成長する可能性が高いです。

哺乳類細胞発酵技術市場：競合情勢

哺乳類細胞発酵市場は、細胞培養の技術的進歩によって牽引されています。哺乳類細胞発酵技術に対する需要の高まりは、多くの用途に利用されるため、大手企業が資本を投下するための様々な市場の可能性を生み出しています。これらの業界プレーヤーは主に、世界な足跡を築き市場競争を維持するために、買収、提携、パートナーシップ、合併を含むいくつかの戦略を採用しています。さらに、バイオ製造インフラへの支出の増加とともに、バイオプロセス手法を強化するための研究開発が進められていることも、市場の進展を後押ししています。例えば、2023年1月、佛山製薬は、独自に開発した抗PD-1モノクローナル抗体（mAb）セルプルリマブの商業化について、米国で上海ヘンリウス・バイオテック社と独占ライセンス契約を締結しました。これは、米国における佛山製薬の開発にとって重要な転換点となります。

目次

第1章 哺乳類細胞発酵技術市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 哺乳類細胞発酵技術の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 哺乳類細胞発酵技術市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 哺乳類細胞発酵技術市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 哺乳類細胞発酵技術の市場情勢

  • 哺乳類細胞発酵技術の市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 哺乳類細胞発酵技術市場：種類別

  • 概要
    • セグメント別シェア分析：種類別
    • ベビーハムスター腎臓（BHK）細胞発酵
    • チャイニーズハムスター卵巣（CHO）細胞発酵
    • ヒト胎児腎臓（HEK）細胞発酵
    • マウス骨髄腫細胞発酵
    • その他

第8章 哺乳類細胞発酵技術市場：用途別

  • 概要
    • セグメント別シェア分析：用途別
    • 酵素
    • ホルモン
    • モノクローナル抗体
    • 組み換えタンパク質
    • ワクチン
    • その他

第9章 哺乳類細胞発酵技術市場：最終用途別

  • 概要
    • セグメント別シェア分析：最終用途別
    • 学術研究機関
    • バイオ医薬品企業
    • CMO・CDMO

第10章 哺乳類細胞発酵技術市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • フィリピン
    • その他
  • ラテンアメリカ（LATAM）
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ（MEA）
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：哺乳類細胞発酵技術業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • AstraZeneca
    • Danaher
    • Thermo Fisher Scientific, Inc.
    • Regeneron Pharmaceuticals
    • Merck KGaA
    • Lonza
    • Gilead Sciences
    • F. Hoffmann-La Roche Ltd
    • Moderna, Inc
    • Bristol-Myers Squibb
    • Amgen
    • Sartorius AG
    • Others

第12章 AnalystViewの全方位的分析

目次
Product Code: ANV4754

REPORT HIGHLIGHT

Mammalian cell fermentation technology Market size was valued at US$ 50,789.43 Million in 2024, expanding at a CAGR of 8.99% from 2025 to 2032.

Mammalian cells are widely used for producing therapeutic proteins like vaccines, monoclonal antibodies, and other biologics, along with various source materials like Human Embryonic Kidney (HEK) cells, Chinese Hamster Ovary (CHO) cells, and others. The mammalian cell fermentation technology industry will likely see significant growth in the forecasted years due to several factors, such as the rising demand for biosimilars and biologics, the increasing prevalence of chronic diseases, and advancements in mammalian cell culture techniques.

Mammalian Cell Fermentation Technology Market- Market Dynamics

Increasing demand for biologics and biosimilars to propel market growth

The mammalian cell fermentation technology industry is witnessing a significant rise due to the rising demand for biosimilars and biologics. These treatments are important in managing various conditions, including infectious diseases, cancer, and autoimmune conditions. Additionally, mammalian cell fermentation technology keeps expanding as pharmaceutical firms invest more in the creation of novel biologics. However, a vital factor restraining the widespread use of this technology is the high expenses associated with its manufacturing process. Furthermore, the rise in chronic diseases like cancer, diabetes, and heart disease resulted in a growth in the mammalian cell fermentation technology market. There is an ongoing demand for mammalian cell fermentation technologies as many diseases need long-term treatment, often with biologics. As a result, the market for mammalian cell fermentation technology is projected to grow over the coming years owing to the constant demand for biosimilars and biologics along with the rise in chronic illnesses.

Mammalian Cell Fermentation Technology Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.99% over the forecast period (2025-2032)

Based on type segmentation, Chinese hamster ovary (CHO) cell fermentation was predicted to show maximum market share in the year 2024

Based on application segmentation, monoclonal antibodies was the leading application in 2024

Based on end-use segmentation, CMOs & CDMOs was the leading end-use in 2024

On the basis of region, North America was the leading revenue generator in 2024

Mammalian Cell Fermentation Technology Market- Segmentation Analysis:

The global mammalian cell fermentation technology market is segmented on the basis of type, application, end-use, and region.

The market is divided into five categories based on type: baby hamster kidney (BHK) cell fermentation, chinese hamster ovary (CHO) cell fermentation, human embryonic kidney (HEK) Cell fermentation, murine myeloma cell fermentation, and others. The Chinese hamster ovary (CHO) cell fermentation sector is expected to dominate the market. CHO cells have prompted immense attention because of their ability to efficiently manufacture complex therapeutic proteins. Additionally, the rise in demand can be attributed to various factors such as the optimization of culture media and conditions, advancements in genetic engineering techniques for enhancing cell line development, and a robust regulatory environment.

The market is divided into six categories based on application: enzymes, hormones, monoclonal antibodies, recombinant proteins, vaccines, others. The monoclonal antibodies segment is likely to hold the highest market share as high adoption can be attributed to the crucial role that antibodies play in diagnostic and therapeutic applications, leading to growing demand for robust production methods. In addition, advancements in cell line development, bioreactor technologies, and bioprocessing techniques, leading to better product quality, higher yields, and efficient production processes, have fueled the segment's explosive expansion. Likewise, the need for precisely targeted therapies and the increasing prevalence of chronic diseases have also fueled the demand for mammalian antibodies.

The market is divided into three categories based on end-use: academic & research institutes, biopharmaceutical companies, and CMOs & CDMOs. The CMOs & CDMOs sector is likely to maintain its dominance during the forecast period due to the complex manufacturing techniques that CDMOs and CMOs specialize in. These organizations provide a simplified and affordable solution for businesses aiming to outsource their manufacturing processes, allowing them to concentrate on development and research. Moreover, quality standards and regulatory requirements are more stringent, thereby pharmaceutical businesses to collaborate with reputable CMOs and CDMOs that maintain the proficiency to comply with these demands.

Mammalian Cell Fermentation Technology Market- Geographical Insights

North America accounts for the largest share of the mammalian cell fermentation technology market. The market growth is attributed to the region's highly developed healthcare sector, favorable government regulations, and a strong presence of significant biopharmaceutical companies. Moreover, the rising demand for biologics and biosimilars and the rising incidence of chronic illnesses are attributed to driving the region's market growth.

The Asia Pacific region is likely to increase at a swift rate owing to the accessibility of trained staff at a reduced cost, the favorable regulatory environment, and rising investments by multinational corporations.

Mammalian Cell Fermentation Technology Market- Competitive Landscape:

The market for fermenting mammalian cells is being driven by technological advancements in cell culture. The rising demand for mammalian cell fermentation technology for numerous applications has created various market possibilities for major players to capitalize on. These industry players primarily adopt several strategies that involve acquisitions, collaborations, partnerships, and mergers to establish a global footprint and maintain market competition. Moreover, the market's progress is fostered by the ongoing research and development efforts to enhance bioprocessing methods, along with the rising spending on biomanufacturing infrastructure. For instance, in January 2023, Fosun Pharmahas signed an exclusive license agreement with Shanghai Henlius Biotech, Inc. in the United States (US) for the commercialization of Henlius independently developed anti-PD-1 monoclonal antibody (mAb) serplulimab. This marks a significant turning point for Fosun Pharma's development in the US.

Recent Developments:

In July 2023, Lonza launched the TheraPRO(R) CHO Media System, an innovative cell culture platform that streamlines procedures and optimizes productivity and protein quality when utilized with GS-CHO cell lines. The launch of this technology supports biotechnology and pharmaceutical companies that manufacture therapeutic proteins to enhance product quality while streamlining time-to-market.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • AstraZeneca
  • Danaher
  • Thermo Fisher Scientific, Inc.
  • Regeneron Pharmaceuticals
  • Merck KGaA
  • Lonza
  • Gilead Sciences
  • F. Hoffmann-La Roche Ltd
  • Moderna, Inc
  • Bristol-Myers Squibb
  • Amgen
  • Sartorius AG
  • Others

GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Baby Hamster Kidney (BHK) Cell Fermentation
  • Chinese Hamster Ovary (CHO) Cell Fermentation
  • Human Embryonic Kidney (HEK) Cell Fermentation
  • Murine Myeloma Cell Fermentation
  • Others

GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Enzymes
  • Hormones
  • Monoclonal Antibodies
  • Recombinant Proteins
  • Vaccines
  • Others

GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

  • Academic & Research Institutes
  • Biopharmaceutical Companies
  • CMOs & CDMOs

GLOBAL MAMMALIAN CELL FERMENTATION TECHNOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Mammalian Cell Fermentation Technology Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Mammalian Cell Fermentation Technology Market Snippet by Type
    • 2.1.2. Mammalian Cell Fermentation Technology Market Snippet by Application
    • 2.1.3. Mammalian Cell Fermentation Technology Market Snippet by End-use
    • 2.1.4. Mammalian Cell Fermentation Technology Market Snippet by Country
    • 2.1.5. Mammalian Cell Fermentation Technology Market Snippet by Region
  • 2.2. Competitive Insights

3. Mammalian Cell Fermentation Technology Key Market Trends

  • 3.1. Mammalian Cell Fermentation Technology Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Mammalian Cell Fermentation Technology Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Mammalian Cell Fermentation Technology Market Opportunities
  • 3.4. Mammalian Cell Fermentation Technology Market Future Trends

4. Mammalian Cell Fermentation Technology Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Mammalian Cell Fermentation Technology Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Mammalian Cell Fermentation Technology Market Landscape

  • 6.1. Mammalian Cell Fermentation Technology Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Mammalian Cell Fermentation Technology Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024&2032 (%)
    • 7.1.2. Baby Hamster Kidney (BHK) Cell Fermentation
    • 7.1.3. Chinese Hamster Ovary (CHO) Cell Fermentation
    • 7.1.4. Human Embryonic Kidney (HEK) Cell Fermentation
    • 7.1.5. Murine Myeloma Cell Fermentation
    • 7.1.6. Others

8. Mammalian Cell Fermentation Technology Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024&2032 (%)
    • 8.1.2. Enzymes
    • 8.1.3. Hormones
    • 8.1.4. Monoclonal Antibodies
    • 8.1.5. Recombinant Proteins
    • 8.1.6. Vaccines
    • 8.1.7. Others

9. Mammalian Cell Fermentation Technology Market - By End-use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-use, 2024&2032 (%)
    • 9.1.2. Academic & Research Institutes
    • 9.1.3. Biopharmaceutical Companies
    • 9.1.4. CMOs & CDMOs

10. Mammalian Cell Fermentation Technology Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Mammalian Cell Fermentation Technology Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Mammalian Cell Fermentation Technology Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Mammalian Cell Fermentation Technology Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Mammalian Cell Fermentation Technology Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Mammalian Cell Fermentation Technology Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Mammalian Cell Fermentation Technology Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. AstraZeneca
    • 11.2.2. Danaher
    • 11.2.3. Thermo Fisher Scientific, Inc.
    • 11.2.4. Regeneron Pharmaceuticals
    • 11.2.5. Merck KGaA
    • 11.2.6. Lonza
    • 11.2.7. Gilead Sciences
    • 11.2.8. F. Hoffmann-La Roche Ltd
    • 11.2.9. Moderna, Inc
    • 11.2.10. Bristol-Myers Squibb
    • 11.2.11. Amgen
    • 11.2.12. Sartorius AG
    • 11.2.13. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us